series-a
Stage
1
Investors
About
NeuroClues develops a CE-marked medical device that uses high-speed eye-tracking technology combined with AI algorithms to extract neurological biomarkers from eye movements, aiding in the early diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's.
Explore neuroClues's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.